Active, Not Recruiting Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer NCT01167712 Conditions Adnexal Diseases, Brenner Tumor, Endocrine System Diseases, +50 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States University of South Alabama Mitchell Cancer Institute — Mobile, Alabama, United States Providence Alaska Medical Center — Anchorage, Alaska, United States Saint Joseph's Hospital and Medical Center — Phoenix, Arizona, United States View all 564 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer NCT00565851 Conditions Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, +51 more Locations Anchorage Associates in Radiation Medicine — Anchorage, Alaska, United States Anchorage Radiation Therapy Center — Anchorage, Alaska, United States Alaska Breast Care and Surgery LLC — Anchorage, Alaska, United States Alaska Oncology and Hematology LLC — Anchorage, Alaska, United States View all 709 locations View more locations Show fewer locations Loading locations... View Trial Details
